J-Clinic: One year of progress
One year on from its inception, MIT/J-Clinic Chair Professor Anantha P. Chandrakasan talks to Opening Doors about progress on this groundbreaking MIT/Community Jameel collaboration.
Anantha P. Chandrakasan, Dean of the MIT School of Engineering and the Vannevar Bush Professor of Electrical Engineering and Computer Science, was appointed Chair of the Abdul Latif Jameel Clinic for Machine Learning in Health (J-Clinic) in October 2018. Over the last year, Anantha and the J-Clinic team have worked hard to establish strong relationships with healthcare providers in the US and further afield, with the aim of expanding the boundaries of global healthcare research to deliver real-world impacts in disease prevention, diagnostics, and drug discovery and development.
Q. It’s one year since J-Clinic was launched. Are you pleased with progress so far?
AC: It’s been a tremendous year for J-Clinic. Our biggest achievement has been to define a community of researchers working at the intersection of health and artificial intelligence, in areas such as early diagnosis of diseases, discovery of drugs, and personalized medicine.
A vital part of this step is raising awareness of this community at MIT, and we have started to do that very successfully over the past 12 months. Our entire modus operandi is based on collaborating with healthcare providers, and that takes time to organize, but our Principal Investigators (PIs) are now working with hospitals around the US – and already beginning to make significant progress.
Of course, setting up any new research center takes time. During our first year we have focused on putting out a call for proposals, getting the resulting proposals reviewed, and getting faculty members funded. We’ve also recruited some of the best talent at MIT, with graduate fellowship awards that allowed us to bring in computer science and biological engineering talent to our community.
Q. Are any projects making particularly good progress?
AC: In total, we’re currently funding 18 projects, all of which are working with hospitals in some capacity. Most of these hospitals are in the US, but we’re also in discussions with other hospitals, including one in Japan which Mr Jameel introduced us to – and we’re making good progress.
One of our faculty leads at J-Clinic, Regina Barzilay, is working in collaboration with Massachusetts General Hospital here in Boston, to help predict breast cancer using mammogram data.
Regina is also behind our annual symposium into AI-powered drug discovery and manufacturing that will be taking place in Spring 2020. Community Jameel has been instrumental in publicizing this workshop.
Another member of our community, professor Dina Katabi, is working in collaboration with the Mayo Clinic in Rochester, Minnesota. She is doing amazing work to monitor Epilepsy seizures using radio signals without any devices on the patient’s body.
That’s just getting off the ground, but it looks promising.
Q. How receptive are hospitals to these kinds of collaborations?
AC: Over the last decade, hospitals have become very interested in embracing AI to make better diagnoses and treatments. The understanding of what this incredible technology is capable of is still developing, but there’s an enormous potential for research in this area, and I think they are beginning to appreciate that.
For example, in many cases, it’s not enough to merely diagnose disease. We need to be able to explain why the algorithm did what it did. Our goal is to augment the knowledge of medical professionals and help them provide better medical treatment.
We’re thinking about how machines and humans can work together in better ways. In fact, professors Julie Shah and Bill Aulet are running the MIT Collaborative Intelligence Competition for MIT students – with a US$ 50,000 prize – to explore how collaborative AI and computing can be used to empower humankind. Health will clearly be a major part of this.
Julie herself, for example, worked on robotics and how robot nurses can schedule various procedures in hospitals. There are lots of areas where we see automation and humans working together.
A big part of what we do at J-Clinic is to encourage adoption by educating medical personnel, and this is another area where we have made significant strides in our first year. Obviously, the technology behind AI is moving fast, but health providers’ willingness to adopt these technologies is growing quickly too.
Q. How important is dialogue to this? For hospitals to work with you to identify new opportunities where AI can make a difference?
AC: It is crucial, and this brings me to the entrepreneurship aspects of J-Clinic.
Led by the Deshpande Center and the MIT Innovation Initiative, we launched the Proto Ventures Program to create new paths for Ideas to Impact. The first Proto Venture focus area supports J-Clinic’s mission to incubate research at the intersection of computer science, big data, and the life sciences.
Rather than starting with a solution, the J-Clinic Proto Venture starts by defining unrecognized opportunities before constructing solutions within the MIT network of students, researchers, and faculty.
This allows both MIT and J-Clinic to capture hidden value from scientific discovery, build an ecosystem, and train entrepreneurs to build ventures that address the big problems with global markets.
Q. What are the main challenges you’ve faced in J-Clinic’s first year of operation?
AC: The success of what we’re doing will largely depend on the datasets we can access, but, obviously, there’s a lot of sensitivity around hospitals releasing data. We’re learning, we’re adapting, and we’re making great progress in building these kinds of connections, and building secure solutions.
It’s an area where I would love to see even more acceleration. But I’m confident that once those collaborations are in place, we’re going to have access to a tremendous amount of data. What we’re trying to do, as a clinic, is get more institutional access so we can create an even broader community.
Q. Was it difficult to identify the 18 projects you’re currently funding?
AC: We had 43 applications for our first round of funding, each of which was of a very high standard. Many of them involved multiple faculty members, so there was quite a broad engagement of the community here at MIT.
It was a good turnout, and I believe it’s going to grow because the number of people doing healthcare is growing, and the number of people doing AI is growing, and now J-Clinic has established this community.
We’re also trying to create other collaborations within J-Clinic in terms of broader impact, and we’re in discussions with companies and foundations about how we might work with them to expand the footprint and impact of J-Clinic.
Q. Is it important to establish connections with any of the other Jameel Labs at MIT?
AC: Yes it is, and we have made good progress in this regard, particularly in education, in collaboration with the Abdul Latif Jameel World Education Lab (J-WEL). It’s important for me that, as well as a capitalizing on the tremendous hospital network that we have in the US, J-Clinic is able to have an impact in less developed markets, such as rural communities in India, where one of our grantees is already doing some interesting work.
We also want to be able to bring essential technologies and low-cost medical devices coupled with AI, to remote parts of Africa, and other parts of the developing world – and I believe the Abdul Latif Jameel Poverty Action Lab (J-PAL) could be central to what we do in this space.
Q. Finally, what should we expect for the year ahead?
AC: I expect an early pay-off in terms of the research that we have begun already, with real datasets being analyzed, papers being published, and early adoption into hospitals.
I hope to see progress with the Proto Ventures program, where we identify exciting new areas to develop technology that can result in direct start-ups, and I anticipate a tremendous amount of progress on education, with lots of AI and health workshops, and bootcamps and symposia on drug discovery.
I’m also hoping to see at least one major industry collaboration, where we’re able to amplify the funding that we get to cover more areas, to get more people involved, and to strengthen the J-Clinic community even further.
Bold IDEA to combat the rise of infectious diseasesFady Jameel discusses the pressing need to tackle the rise of infectious diseases to prevent global health crises. ...Read more
J-WAFS in action – combating food contaminationTim Swager, the John D. MacArthur Professor of Chemistry at MIT, and coworkers, have developed a new way to bring a fast, easy, and affordable food safety sensing technology to industry and consumers. ...Read more
AI in healthcare: a quiet revolution about to get loudFady Jameel discusses how artificial intelligence (AI) is set to transform the global healthcare industry. ...Read more
Artistic renaissance redefining our global presenceIt’s never been a better time to be an artist – or an arts enthusiast – in the Middle East. With a rich cultural history, one increasingly unafraid to splice with modern perspectives, the region is attracting the world’s gaze as never before. ...Read more
Developing a new planning model for large water projectsJ-WAFS’ research explores how city planners can best prepare for the uncertainties of climate change. ...Read more
Water flows through the 2018 World Economic Forum Global Risks ReportThis January 2500 delegates and 70 world leaders from 100 different countries braved the heaviest snowfall in decades to meet in Davos, Switzerland at the World Economic Forum (WEF). ...Read more
A war on waste and a spray that stays: J-WAFS cultivates innovation to address pressing food and agriculture problemsA coating that reduces food waste by increasing the shelf life of produce, and a spray that reduces pollution caused by pesticide run-off, are among two of the latest innovations to win recognition from the Abdul Latif Jameel World Water and Food Security Lab (J-WAFS), in the Massachusetts Institute of Technology’s (MIT) second annual Rabobank-MIT Food and Agribusiness Innovation Prize. Picking ...Read more
Securing food and water for allMankind’s most significant issues are being tackled by an elite group of researchers and entrepreneurs at the home of the Abdul Latif Jameel World Water and Food Security Lab (J-WAFS) at Massachusetts Institute of Technology (MIT). The world’s population is predicted to grow by more than two billion by the mid-21st Century, according to the UN Department of Economic and Social Affairs . That ...Read more
Kids in the classroom: Improving education for children in developing economiesNew ways to potentially increase the number of children enrolled in and attending full-time education in low- and middle-income countries have been identified by a comprehensive new report published by the Abdul Latif Jameel Poverty Action Lab (J-PAL), based at the Massachusetts Institute of Technology. The report – Roll Call: Getting Children into School  – drew lessons from 58 randomized ...Read more
J-WAFS in action: providing safe drinking water through woodRohit Karnik, Associate Professor of Mechanical Engineering at MIT, and Amy Smith, Senior Lecturer at MIT’s Department of Mechanical Engineering and founding director of D-Labs at MIT, are leading a group of researchers hoping to harness the natural qualities of xylem wood to provide safe, affordable drinking water to low-income groups. Opening Doors spoke to Rohit Karnik, Amy Smith, and team me ...Read more